State Street
VAXX

State Street’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

State Street’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-799,273
Closed -$573K – 4441
2024
Q1 		$573K Hold
799,273
– – ﹤0.01% 3611
2023
Q4 		$679K Sell
799,273
-33,200
-4% -$32.1K ﹤0.01% 3574
2023
Q3 		$1.14M Buy
832,473
+56,570
+7% +$123K ﹤0.01% 3494
2023
Q2 		$1.96M Buy
775,903
+654,969
+542% +$1.39M ﹤0.01% 3423
2023
Q1 		$275K Buy
120,934
+66,200
+121% +$168K ﹤0.01% 3955
2022
Q4 		$76.6K Buy
+54,734
New +$91.9K ﹤0.01% 4444

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

State Street's VAXX Position: Q2 2024 in Review

State Street sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 799,273 shares — an estimated $573K sold.

State Street first reported a position in VAXX in Q4 2022 and held it in 6 quarters. The position peaked at $1.96M in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • State Street reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • State Street sold 799,273 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $573K.
  • State Street first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2022 and held it in 6 quarters.
  • State Street's Vaxxinity, Inc. Class A Common Stock position peaked at $1.96M in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.